Skip to Content
Director, Division of Neurology, Behavior, and DevelopmentDirector, Muscular Dystrophy ClinicDirector, Iowa Neuromuscular ProgramProfessor of Pediatrics
- NeurologyProfessor of
Primary Office: 2503 JCPIowa City, IA 52242
BS, Psychology, with highest distinction, University of IowaMD, Medicine, University of Iowa Carver College of Medicine
Residency, Pediatrics, University of IowaResidency, Neurology, University of IowaFellowship, Child Neurology, University of IowaFellowship, Genetics, University of Iowa
Certified, Child & Dependent Adult Abuse trainingCertified, CPR through American Heart AssociationDiplomate, American Board of Psychiatry and Neurology, with special competence in Child NeurologyDiplomate, American Board of Pediatrics
I am interested in all aspects of Clinical Pediatric Neurology. Particular interests include neuromuscular disorders and the neuropsychological outcome of childhood stroke. My research career began with using genetic linkage, then a putative mouse model, to identify the gene causing facioscapulohumeral dystrophy. I closed my laboratory in 1998 due to increasing clinical and administrative demands, and my current academic efforts have been focused on improving the quality of care for patients with neuromuscular disease. I have maintained an active interest in the impact of molecular genetics on neuromuscular diseases (diagnosis, pathophysiology and treatment). I have served on NIH and CDC working groups to define the direction of research on neuromuscular disease in the future. I have become increasingly involved in collaborative clinical research efforts, many of which are laying a groundwork for clinical trials. I am currently a co-PI (with Paul Romitti, PhD) on the Iowa MDSTARnet project, a CDC sponsored, multi-center Duchenne/Becker Muscular Dystrophy surveillance and epidemiology project. I am co-PI on one project of the University of Iowa's NIH funded Wellstone Center, directed by Kevin Campbell, PhD and Steve Moore, MD, PhD. My project involves defining the phenotypes of patients with FRKP mutations and will extend nationwide. This clinical project was a key component of this successful NIH application. I am also the Iowa PI in the United Dystrophinopathy project; a genotype-phenotype study headed by Dr. Kevin Flanigan at the University of Utah and recently funded by the NIH.
Date Last Modified: 06/06/2016 -
Copyright © 2015 The University of Iowa. All Rights Reserved.